Complete Response in Metastatic Hepatocellular Carcinoma with Cardiac and Lung Involvement via Multimodality Treatment
| Autor: | Kun-Feng Tsai, Huei-Lung Liang, Shan-Ho Chan, Jerry C H Tsai, Ming-Feng Li, Chu-Kuang Chou, Jimmy Wei-Hwa Tan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Extremely Poor
Sorafenib Oncology medicine.medical_specialty Medicine (General) business.industry Multimodality Treatment medicine.medical_treatment Case Report General Medicine Case presentation Immunotherapy Lung involvement R5-920 Internal medicine medicine metastatic hepatocellular carcinoma multimodality treatment Metastatic hepatocellular carcinoma business Complete response medicine.drug tumor thrombi in inferior vena cava or right atrium |
| Zdroj: | Medicina, Vol 57, Iss 849, p 849 (2021) Medicina |
| ISSN: | 1648-9144 |
| Popis: | Background: Until recently, advanced HCC patients with major vessel and cardiac involvement have had an extremely poor prognosis without satisfactory treatment. Case presentation: A 63-year-old Taiwanese male presented with metastatic HCC with RA and IVC thrombi, as well as pulmonary metastases that were successfully treated by multimodal management, encompassed by surgical thrombectomy, concurrent systemic sorafenib and locoregional therapies, and immunotherapy. The patient has achieved a complete response over the past 33 months. Conclusions: Through this case report, which shows a successful outcome via multimodal management, a more aggressive approach should be considered when a patient is expected to tolerate the risks and side effects of various treatments. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|